๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

WR Grace 2Q 2007: core operations: Grace Davison

Publisher
Elsevier Science
Year
2007
Weight
49 KB
Volume
2007
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

WR Grace 3Q 2007: core operations: Grace
WR Grace 3Q 2007: core operations: Grace Davison
๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science โš– 52 KB

winning back lost customers and gaining new ones. The company's American enzymes producer Genencor is finally winning back customers and territory after several quarters of dwindling custom and single-figure growth rates.

WR Grace 2Q 2005: Davison Chemicals
WR Grace 2Q 2005: Davison Chemicals
๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Elsevier Science โš– 35 KB

the use of LSBC's technologies. BioCatalytics Inc is a leading provider of enzymes and enzymatic technology, with one of the largest product lines of enzymes for chemical synthesis available anywhere. Large Scale Biology Corp is a biotechnology company developing and biomanufacturing biotherapeutics

Grace reports 1Q 2008 financial results:
Grace reports 1Q 2008 financial results: core operations: Grace Davison
๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science โš– 46 KB

longer economically viable. The employees affected by the closure will be redeployed to other operations at the Niederkassel site (particularly alcoholates production for biodiesel catalysts).

WR Grace reports 2Q 2010 results: Grace
WR Grace reports 2Q 2010 results: Grace Davison: segment operating income up 30%
๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science โš– 52 KB

## Umicore 1H 2010 For its 1H 2010, Umicore has reported revenues of โ‚ฌ987.1 M (โ‚ฌ860.2 M for its 1H 2009), recurring EBIT of โ‚ฌ186.3 M (โ‚ฌ49.5 M), EBITDA of โ‚ฌ244.3 M (โ‚ฌ111.6 M), basic EPS of โ‚ฌ1.24 (โ‚ฌ0.18), R&D expenditure of โ‚ฌ66.2 M (6% of revenues), and capital expenditure of โ‚ฌ75.5 M. An interim div